3Capomolla S,Febo O,Gnemmi M,et al.β-blockade therapy inchronic heart failure:diastolic function and mitral regurgitation improvement bycarvedilol.AmHeart J,2000;139:596
4Khattar RS,Senior R,Soman P,et al.Regression of left ventricular remolding in chronic heart failure:Comparative and combined effect sofcatopril and carvedilol.Am Heart J,2001 ;142:704
1The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure[J]. N Engl J Med, 1997,336(8) :525-533.
2Kulbertus H. L'etude clinique dumois. L'etude RALES(randomized aldactone evaluation study ) [ J ]. Rev Med Lieee, 1999.54 (9) : 770-772.
3Cleland JGF, McGowan J, Clark A. The evidenee for β bl'ockers in heart failure[ J]. BMJ, 1999,318(7187) :824-825.
4Pitt B, Segal R, Martinez FA, et al. Randomized trial of losartan versus captopril in patients over 65 with heart failure( Evaluation of Losartan in the Elderly Study, ELITE) [ J ]. Lancet, 1997,349 (9054) : 747-752.
5Pitt B, Poole-Wilson PA, Segal R, et al. Effect of losartan compared with captopfil on mortality in patients with symptomatic heart failure:randomized trial-the losartan heart failure survial study ELITE Ⅱ[J]. Lancet,2000,355(9215) : 1582-1587.
6Cohn JN, Tognoni G, Glazer R, et al. Baseline demographics of the Valsartan Heart Failure Trial. Val-HeFT Investigators[ J]. Eur J Heart Fail,2000,2(4) :439-446.
7Dilenarda A,De Maria R,Gavazzi A, et al. Long-term survival effect of motoprolol in dilated cardiomyopathy. The SPIC (Italian Muhicentre Cardiomyopathy Study)Group [J]. Heart, 1998,79(4) :337-344.
8CIBIS-Ⅱ Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study Ⅱ( CIBIS-Ⅱ ) : a randomized trial [ J ]. Lancet, 1999,353(9146) :9-13.
9Hjalmarson A, Goldstein S, Fagerberg B, et al. Effect of metoprolol CR/XL in chronic heart failure:metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF) [ J ]. Lancet, 1999,353(9169) :2001-2007.
10Parcker M, Coats AJ, Fowler MB, et al. The Effect of carvedilol on survival in severe chronic heart failure [ J]. N Engl J Med, 2001,344 (22) :1651-1658.
